CRL
Charles River Laboratories
298.00$
-0.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.98 | 4.28 | 2.51 | 3.73 | 4.88 | 3.12 | 3.38 | 4.15 | 4.33 | 3.00 | 0.84 | 3.71 | 12.01 | |
| 1.53 | 1.56 | 1.65 | 1.66 | 1.71 | 2.00 | 2.37 | 2.42 | 1.72 | 1.59 | 1.37 | 1.39 | 6.14 | |
| 0.44 | 0.38 | 0.32 | 0.32 | 0.37 | 0.34 | 0.26 | 0.35 | 0.47 | 0.36 | 0.46 | 0.41 | 1.71 | |
| 0.71 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.04 | 0.74 | -0.93 | -0.22 | 1.39 | -0.83 | 0.03 | 0.23 | -0.10 | 0.14 | -2.17 | 0.06 | -2.09 | |
| 1.28 | 1.52 | 1.53 | 0.76 | 0.75 | 1.48 | 1.17 | 0.72 | 0.72 | 1.81 | 1.14 | 0.64 | 4.36 | |
| -1.54 | -4.62 | -1.65 | -1.19 | -0.41 | -1.49 | -0.89 | -0.76 | -0.68 | -1.50 | -8.33 | 0.58 | -10.05 | |
| 0.08 | 0.12 | – | – | – | – | – | – | – | – | – | – | – | |
| 0.00 | 0.00 | -0.18 | -0.17 | -1.95 | 0.00 | -6.94 | -0.15 | 0.00 | 0.00 | -4.25 | -2.38 | -6.68 | |
| -3.15 | – | – | – | -1.82 | -1.41 | 5.25 | -3.88 | -2.96 | -1.04 | 11.37 | -0.77 | 6.64 | |
| -3.16 | 2.39 | 0.35 | -5.51 | -4.02 | -1.48 | -2.07 | -4.60 | -3.09 | -1.05 | 7.10 | -3.40 | -0.44 | |
| -0.84 | 2.30 | 1.04 | -3.04 | 0.59 | -0.12 | 0.51 | -0.95 | 0.50 | 0.14 | -0.36 | 0.87 | 1.15 | |
| 2.70 | 2.76 | 0.98 | 2.97 | 4.13 | 1.64 | 2.21 | 3.43 | 3.61 | 1.19 | -0.30 | 3.07 | 7.64 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.